RMD:ASX
ResMed
AU$31.68
arrow_downward
-1.28%(-0.41) 1 天
9月4日, GMT+10 16:10:25 · AUD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 RMD 生成关键数据洞见…
开盘价
AU$31.95
最高价
AU$32.00
最低价
AU$31.68
市值
三二九.四〇亿
平均成交量
一九一.六八万
成交量
一〇二.六六万
52 周最高价
AU$43.29
52 周最低价
AU$25.50
流通股数
一.四四亿
员工人数
一万
开盘价
AU$31.95
最高价
AU$32.00
最低价
AU$31.68
市值
三二九.四〇亿
平均成交量
一九一.六八万
成交量
一〇二.六六万
52 周最高价
AU$43.29
52 周最低价
AU$25.50
流通股数
一.四四亿
员工人数
一万
新闻报道
来自网络来源和新闻合作伙伴
Kalkine Media
·
19小时前
ResMed Director Peter Farrell Executes Sale of 970 Shares via 10b5-1 Trading Plan
Stock Titan
·
1天前
ResMed (RMD) director sells shares under trading plan
资料
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
ResMed简介